You are here

  • Home
  • Archive
  • Volume 70, Issue 12
  • RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease

Article metrics

Article menu
Hepatology
Original research
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease

 

Online download statistics by month:

Online download statistics by month: December 2020 to March 2024

AbstractFullPdf
Dec 2020385357175
Jan 202113441217771
Feb 2021488475224
Mar 2021249245198
Apr 202115315297
May 2021221220131
Jun 2021229230129
Jul 2021197196129
Aug 2021177176146
Sep 2021184183139
Oct 2021208207143
Nov 2021715710362
Dec 2021505514380
Jan 2022265259198
Feb 2022260251157
Mar 2022254253136
Apr 2022323323146
May 2022266280147
Jun 2022213203114
Jul 2022181185140
Aug 2022154155108
Sep 2022181179141
Oct 2022170171122
Nov 202214914399
Dec 202214313677
Jan 202311711664
Feb 202313913568
Mar 202313913798
Apr 202310510594
May 2023105101107
Jun 202312711588
Jul 202312611892
Aug 202310910675
Sep 202312411874
Oct 202317015977
Nov 202314212783
Dec 20231079351
Jan 2024785657
Feb 2024696051
Mar 2024130118171
Total940190845859